Ligand Pharmaceuticals Incorporated

LGNZZ ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 May 4, 2026 PRIMARY DOCUMENT
SCHEDULE 13D May 1, 2026
144 May 1, 2026
SCHEDULE 13G May 1, 2026
SCHEDULE 13G May 1, 2026
8-K Apr 30, 2026 8-K
DEFA14A Apr 28, 2026 DEFA14A
DEFA14A Apr 27, 2026 DEFA14A
8-K Apr 27, 2026 8-K
ARS Apr 21, 2026 ARS
DEFA14A Apr 21, 2026 DEFA14A
DEF 14A Apr 21, 2026 DEF 14A
4 Apr 2, 2026 PRIMARY DOCUMENT
4 Apr 2, 2026 PRIMARY DOCUMENT
144 Apr 1, 2026
4 Mar 31, 2026 PRIMARY DOCUMENT
4 Mar 27, 2026 PRIMARY DOCUMENT
4 Mar 27, 2026 PRIMARY DOCUMENT
4 Mar 27, 2026 PRIMARY DOCUMENT
SCHEDULE 13G/A Mar 27, 2026
4 Mar 25, 2026 OWNERSHIP DOCUMENT
144 Mar 23, 2026
4 Mar 13, 2026 PRIMARY DOCUMENT
144 Mar 11, 2026
4 Mar 6, 2026 PRIMARY DOCUMENT
← Newer Page 3 of 89 · 2214 filings Older →